Physician profile
Jonathan S Shaw
NPI 1356672794
$1,859.67
in general payments reported to CMS, 2019-2025
10 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.90 · 2021: $152 · 2022: $30.72 · 2023: $18.29 · 2024: $1,002 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $863 · Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $862.59 |
| Food and Beverage | $734.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $708.29 | 2024 | Ecoin Device Kit |
| Boston Scientific Corporation | $330.85 | 2025 | Axonics, Bulkamid, General - Female Sui |
| Axonics, INC. | $234.86 | 2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $183.28 | 2025 | |
| Medtronic, INC. | $116.95 | 2021-2025 | Interstim |
| Depuy Synthes Sales INC. | $89.21 | 2021-2022 | |
| Allergan, INC. | $79.90 | 2019 | |
| Coloplast Corp | $74.86 | 2023-2025 | Speedicath |
| Abbvie INC. | $21.95 | 2025 | |
| Astellas Pharma US INC | $19.52 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.